Nationwide Fund Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-95,513
| Closed | -$237K | – | 1136 |
|
|
2017
Q3 | $237K | Buy |
95,513
+13,380
| +16% | +$33.2K | ﹤0.01% | 2560 |
|
|
2017
Q2 | $226K | Buy |
82,133
+31,180
| +61% | +$85.8K | ﹤0.01% | 2575 |
|
|
2017
Q1 | $154K | Buy |
50,953
+1,074
| +2% | +$3.25K | ﹤0.01% | 2691 |
|
|
2016
Q4 | $158K | Sell |
49,879
-5,248
| -10% | -$16.6K | ﹤0.01% | 2711 |
|
|
2016
Q3 | $188K | Buy |
55,127
+12,273
| +29% | +$41.9K | ﹤0.01% | 2655 |
|
|
2016
Q2 | $98K | Buy |
42,854
+4,105
| +11% | +$9.39K | ﹤0.01% | 2919 |
|
|
2016
Q1 | $97K | Sell |
38,749
-3,013
| -7% | -$7.54K | ﹤0.01% | 2833 |
|
|
2015
Q4 | $138K | Hold |
41,762
| – | – | ﹤0.01% | 2722 |
|
|
2015
Q3 | $101K | Hold |
41,762
| – | – | ﹤0.01% | 2893 |
|
|
2015
Q2 | $122K | Sell |
41,762
-5,638
| -12% | -$16.5K | ﹤0.01% | 2953 |
|
|
2015
Q1 | $190K | Sell |
47,400
-1,934
| -4% | -$7.75K | ﹤0.01% | 2713 |
|
|
2014
Q4 | $149K | Hold |
49,334
| – | – | ﹤0.01% | 2777 |
|
|
2014
Q3 | $125K | Buy |
49,334
+969
| +2% | +$2.46K | ﹤0.01% | 2900 |
|
|
2014
Q2 | $119K | Buy |
48,365
+12,384
| +34% | +$30.5K | ﹤0.01% | 2975 |
|
|
2014
Q1 | $96K | Hold |
35,981
| – | – | ﹤0.01% | 2747 |
|
|
2013
Q4 | $105K | Hold |
35,981
| – | – | ﹤0.01% | 2939 |
|
|
2013
Q3 | $110K | Buy |
35,981
+3,183
| +10% | +$9.73K | ﹤0.01% | 2905 |
|
|
2013
Q2 | $105K | Buy |
+32,798
| New | +$105K | ﹤0.01% | 2782 |
|